Coert Zuurbier
Universiteit van Amsterdam
H-index: 46
Europe-Netherlands
Top articles of Coert Zuurbier
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE/PKC/NOX axis | Redox Biology | Xiaoling Li Mengnan Wang Jan-Ole Kalina Benedikt Preckel Markus W Hollmann | 2024/2/1 |
Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside | Basic Research in Cardiology | Y Xiao Q Wang H Zhang R Nederlof D Bakker | 2024/3/25 |
Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition | Biomedicine & Pharmacotherapy | Sha Chen Kenneth Overberg Zakiya Ghouse Markus W Hollmann Nina C Weber | 2024/5/1 |
Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium–glucose cotransporter 2 inhibitors | Cardiovascular Research | Paul JM Wijnker Rafeeh Dinani Nico C van der Laan Sila Algül Bjorn C Knollmann | 2024/2 |
Cardioprotective efficacy of limb remote ischaemic preconditioning in rats: discrepancy between a meta-analysis and a three-centre in vivo study | Nabil V Sayour Gábor B Brenner András Makkos Bernadett Kiss Csenger Kovácsházi | 2023/5 | |
Empagliflozin restores the deregulated cardiac endothelial cell transcriptome in vivo upon myocardial ischemia reperfusion injury and reduces the infiltration of immune cells | European Heart Journal | PE Nikolaou N Mylonas M Miliotis I Kostopoulos A Georgoulis | 2023/11 |
Canagliflozin inhibits inflammasome activation in diabetic endothelial cells–Revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin on human diabetic … | Biomedicine & Pharmacotherapy | Xiaoling Li Raphaela P Kerindongo Benedikt Preckel Jan-Ole Kalina Markus W Hollmann | 2023/3/1 |
Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells | Frontiers in physiology | Sha Chen Cees A Schumacher Shirley CM Van Amersfoorth Jan WT Fiolet Antonius Baartscheer | 2023/7/26 |
NLRX1 Prevents M2 Macrophage Polarization and Excessive Renal Fibrosis in Chronic Obstructive Nephropathy | Cells | Ye Liu Lotte Kors Loes M Butter Geurt Stokman Nike Claessen | 2023/12/21 |
Sodium glucose cotransporter-2 inhibitor empagliflozin reduces infarct size independently of sodium glucose cotransporter-2 | Circulation | Sha Chen Qian Wang Andriana Christodoulou Nikolaos Mylonas Diane Bakker | 2023/1/17 |
Nicotinamide riboside cardioprotection is mediated through glycolysis activation | European Heart Journal | Y Xiao Q Wang B Preckel MW Hollmann NC Weber | 2023/11 |
Sodium myo-inositol cotransporter-1, SMIT1, promotes cardiac hypertrophy and fibrosis in pressure overloaded mouse hearts | bioRxiv | Alice Marino Julien Cumps Laura Guilbert Claire Baufays Audrey Ginion | 2023 |
Pharmacological cardioprotection against ischemia reperfusion injury—the search for a clinical effective therapy | Qian Wang Coert J Zuurbier Ragnar Huhn Carolin Torregroza Markus W Hollmann | 2023/5/20 | |
Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological treatments … | Péter Ferdinandy Ioanna Andreadou Gary F Baxter Hans Erik Bøtker Sean M Davidson | 2023/1/1 | |
Malonate protection against acute infarction in isolated mouse hearts is lost in the presence of insulin | European Heart Journal | Q Wang Y Xiao R Nederlof D Bakker MW Hollmann | 2023/11 |
Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus | bmj | Björn Pasternak Peter Ueda Björn Eliasson Ann-Marie Svensson Stefan Franzén | 2019/8/29 |
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects | Jason RB Dyck Samuel Sossalla Nazha Hamdani Ruben Coronel Nina C Weber | 2022/6/1 | |
Comparative study on the cardioprotective effect of selective sodium glucose co-transporter 2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury | Journal of Molecular and Cellular Cardiology | Panagiota Efstathia Nikolaou Nikolaos Mylonas Manousos Makridakis Marina Makrecka-Kuka Aikaterini Iliou | 2022/12/31 |
Direct cardiac effects of SGLT2 inhibitors | Sha Chen Ruben Coronel Markus W Hollmann Nina C Weber Coert J Zuurbier | 2022/3/18 | |
The innate immune receptor NLRX1 protects against cardiac ischemia/reperfusion injury through RISK signaling, mPTP regulation and inhibition of mitochondrial activity | Journal of Molecular and Cellular Cardiology | Yang Xiao Crissy Rudolphi Edgar Nollet Diane Bakker Rianne Nederlof | 2022/12/31 |
